LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
7.54
-0.22 (-2.84%)
May 21, 2026, 3:04 PM CST

SHE:002644 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
565.24524.49397.89406.04397.85374.94
Trading Asset Securities
----2-
Cash & Short-Term Investments
565.24524.49397.89406.04399.85374.94
Cash Growth
46.31%31.82%-2.01%1.55%6.64%-17.06%
Accounts Receivable
459.62474.08413.57382.65435.88344.8
Other Receivables
3.919.4145.5950.562.9812.34
Receivables
463.52493.49459.17433.15498.87357.14
Inventory
293.81289.84339.99369.72363.26258.83
Prepaid Expenses
-0.120.040.9--
Other Current Assets
40.5924.7924.7929.064243.72
Total Current Assets
1,3631,3331,2221,2391,3041,035
Property, Plant & Equipment
976.11986.961,0321,0621,0681,092
Long-Term Investments
67.9169.9355.6664.168.6771.65
Goodwill
9.019.019.019.019.014.47
Other Intangible Assets
72.7373.5576.8779.5576.7971.96
Long-Term Deferred Tax Assets
65.6865.7961.8153.6553.9851.11
Long-Term Deferred Charges
1.781.843.767.6560.89
Other Long-Term Assets
7.077.668.7813.4320.4125.76
Total Assets
2,5632,5472,4702,5282,6062,352
Accounts Payable
294.13263.63213.09310.37314.47214.3
Accrued Expenses
21.6819.0210.2111.4628.869.9
Short-Term Debt
17.821.71010--
Current Portion of Long-Term Debt
-14.713.9213.8913.414.2
Current Portion of Leases
-1.390.820.80.870.5
Current Income Taxes Payable
-8.519.0827.4244.7444.26
Current Unearned Revenue
50.6650.7516.0547.0299.9335.91
Other Current Liabilities
63.5760.9396.5646.7440.2855.78
Total Current Liabilities
447.84440.62379.73467.69542.54374.84
Long-Term Debt
6.26.21526.640.3753.14
Long-Term Leases
2.291.511.051.350.970.81
Long-Term Unearned Revenue
236.29241.4256.1260.96278.15294.96
Long-Term Deferred Tax Liabilities
2.252.32.933.073.180.85
Total Liabilities
694.87692.03654.81759.67865.21724.59
Common Stock
510.66510.66510.66510.66510.66510.66
Additional Paid-In Capital
327.39337.39337.39337.38352.33343.51
Retained Earnings
1,007983.95940.88896.13854.47758.78
Comprehensive Income & Other
0.660.660.961.211.61.62
Total Common Equity
1,8451,8331,7901,7451,7191,615
Minority Interest
23.2622.7925.0923.0622.1712.92
Shareholders' Equity
1,8691,8551,8151,7681,7411,628
Total Liabilities & Equity
2,5632,5472,4702,5282,6062,352
Total Debt
26.2945.4940.7952.6355.668.65
Net Cash (Debt)
538.96479357.1353.41344.26306.29
Net Cash Growth
50.60%34.13%1.04%2.66%12.39%-12.86%
Net Cash Per Share
1.060.940.700.690.670.60
Filing Date Shares Outstanding
510.39510.66510.66510.66510.66510.66
Total Common Shares Outstanding
510.39510.66510.66510.66510.66510.66
Working Capital
915.32892.12842.16771.18761.43659.79
Book Value Per Share
3.623.593.513.423.373.16
Tangible Book Value
1,7641,7501,7041,6571,6331,538
Tangible Book Value Per Share
3.463.433.343.243.203.01
Buildings
-946.04945.9938.67933.74927.81
Machinery
-382.57377.02366.31333.01317.82
Construction In Progress
--1.763.3--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.